A plain-language, continually updated guide from Dr. Matt Chalmers’ clinical reference on hormones and peptides.
Ipamorelin is a selective, lab-made peptide (5 amino acids) that activates the ghrelin receptor (GHSR-1a) — the same receptor that ghrelin, your body’s natural hunger hormone, activates. That activation prompts the pituitary gland to release growth hormone. A landmark 1998 study (Raun et al.) established Ipamorelin as the first truly selective growth-hormone secretagogue, meaning it stimulates GH release without the cortisol or prolactin elevation seen with older compounds in its class.
Because it works through the ghrelin receptor rather than the GHRH receptor, Ipamorelin uses a completely different internal signaling pathway (calcium-based) than GHRH-based peptides like Sermorelin. That’s exactly why the two are so often paired: one primes the pituitary, the other triggers release, and together they produce a stronger, more coordinated growth hormone pulse than either alone.
Ipamorelin is most often used alongside a GHRH-based peptide (like Sermorelin) as part of a personalized growth-hormone-axis protocol, with regular IGF-1 lab monitoring to keep levels in a healthy, age-appropriate range. One practical thing worth knowing: because ghrelin is your body’s hunger signal, Ipamorelin can increase appetite. That’s genuinely useful for patients working on lean-mass gains, but worth planning around if your goal is fat loss. Whether Ipamorelin fits your protocol, and how it’s timed and dosed, is something our providers determine individually.
The growth hormone / IGF-1 pathway Ipamorelin engages ultimately drives protein synthesis — a process that requires adequate dietary protein and amino acids as raw material. Zinc supports pituitary GH synthesis and pulsatility directly, vitamin D modulates GHRH receptor sensitivity, and magnesium is required for the cAMP signaling cascade involved in this pathway. Sleep quality matters too — the majority of natural GH release happens during deep sleep.
Ipamorelin is not FDA-approved for any indication. It’s restricted from 503B compounding but is available through 503A pharmacies with a valid prescription. As with all growth-hormone-axis compounds, active or suspected malignancy is treated as a contraindication, and cancer screening is appropriate before starting any GH-axis protocol. This page is educational and not an offer to prescribe or provide Ipamorelin outside an individualized evaluation.
Yes — growth hormone is well established in endocrine physiology to have two relevant actions: it promotes lipolysis (breakdown of stored fat), and it raises IGF-1, which drives protein synthesis, the process underlying muscle tissue growth and repair. These are textbook actions of growth hormone itself, documented in endocrinology literature independent of any specific product.
These peptides work by stimulating the pituitary gland to release more of the body’s own growth hormone — they don’t introduce growth hormone directly. Because of this, any downstream effect on fat metabolism or muscle tissue would be expected to work through the same natural GH/IGF-1 pathway described above. Individual results depend on many factors, including diet, exercise, sleep, and baseline hormone levels, and are not guaranteed for any specific person. This is why our protocols pair peptide therapy with nutrition, training, and sleep support, rather than treating the peptide as a stand-alone solution.
Learn more about the pathway Ipamorelin works within: Growth Hormone & IGF-1 and Ghrelin, the hormone that shares Ipamorelin’s receptor. Often paired with Sermorelin, or compare with Hexarelin.
This page draws on The Pillars Path: A Root-Cause Guide to Hormones, Peptides, and Metabolic Health by Dr. Matt Chalmers — Pillars of Wellness’ clinical reference on hormone and peptide therapy.
